William McDowall Wells, Director at Valeant Pharmaceuticals International, Inc. (VRX), sold 510,001 shares at $28.05 ($14.3M) on 2010-12-07, disclosed to the SEC on 2010-12-08.
Open-market sale of $14.3M VRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.13 | 490,461 | $13.8M | 96.2% |
| 2 | $26.12 | 2,150 | $56K | 0.4% |
| 3 | $28.05 | 17,390 | $488K | 3.4% |
| Total | $28.12 avg | 510,001 | $14.3M | 100% |
| Filing → |
| ACAD | SELL | 2014-06-10 | $345K | — | Filing → |
| VRX | SELL | 2010-11-12 | $9.7M | — | Filing → |